6 Matching Annotations
  1. Last 7 days
  2. www.sciencedirect.com www.sciencedirect.com
    IRF4 requires ARID1A to establish plasma cell identity in multiple myeloma
    1
    1. scibot 24 Jul 2024
      CVCL_2030

      DOI: 10.1016/j.ccell.2024.05.026

      Resource: (DSMZ Cat# ACC-560, RRID:CVCL_2030)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_2030

      What is this?
      RRID:CVCL_2030
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1535610824002174
  3. May 2024
  4. www.tandfonline.com www.tandfonline.com
    CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cells
    1
    1. scibot 26 May 2024
      CVCL_2030

      DOI: 10.1080/15384047.2024.2314322

      Resource: (DSMZ Cat# ACC-560, RRID:CVCL_2030)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_2030

      What is this?
      RRID:CVCL_2030
    Visit annotations in context

    Tags

    Annotators

    URL

    tandfonline.com/doi/abs/10.1080/15384047.2024.2314322
  5. Feb 2024
  6. www.biorxiv.org www.biorxiv.org
    KDM6A Regulates Immune Response Genes in Multiple Myeloma
    1
    1. scibot 22 Feb 2024
      RRID:CVCL_2030

      DOI: 10.1101/2024.02.12.579179

      Resource: (DSMZ Cat# ACC-560, RRID:CVCL_2030)

      Curator: @mzhang007

      SciCrunch record: RRID:CVCL_2030

      What is this?
      RRID:CVCL_2030
    Visit annotations in context

    Tags

    Annotators

    URL

    biorxiv.org/content/10.1101/2024.02.12.579179v1
  7. Oct 2022
  8. www.sciencedirect.com www.sciencedirect.com
    High-throughput T cell receptor engineering by functional screening identifies candidates with enhanced potency and specificity
    1
    1. scibot 05 Oct 2022
      RRID:CVCL_2030

      DOI: 10.1016/j.immuni.2022.09.004

      Resource: (DSMZ Cat# ACC-560, RRID:CVCL_2030)

      Curator: @evieth

      SciCrunch record: RRID:CVCL_2030

      What is this?
      RRID:CVCL_2030
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1074761322004988
  9. May 2021
  10. www.sciencedirect.com www.sciencedirect.com
    Selective antisense oligonucleotide inhibition of human IRF4 prevents malignant myeloma regeneration via cell cycle disruption
    1
    1. scibot 09 May 2021
      CVCL_2030

      DOI: 10.1016/j.stem.2020.12.017

      Resource: (DSMZ Cat# ACC-560, RRID:CVCL_2030)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_2030

      What is this?
      RRID:CVCL_2030
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1934590920306019
  11. Feb 2021
  12. www.sciencedirect.com www.sciencedirect.com
    Targeted degradation of the enhancer lysine acetyltransferases CBP and p300
    1
    1. scibot 24 Feb 2021
      RRID: CVCL_2030

      DOI: 10.1016/j.chembiol.2020.12.004

      Resource: (DSMZ Cat# ACC-560, RRID:CVCL_2030)

      Curator: @bandrow

      SciCrunch record: RRID:CVCL_2030

      What is this?
      RRID:CVCL_2030
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2451945620305134